Pfizer reports combined sales of $15 billion for Covid vaccine and antiviral treatment in first quarter

Pfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.